Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional study

Mahnaz Bayat, Alireza Fayyazpoor, Afshin Borhani Haghighi, Daniyal Salehi, Hossein Molavi Vardanjan, Maryam Poursadeghfard
doi: https://doi.org/10.1101/2020.10.17.20214429
Mahnaz Bayat
1Clinical neurology research center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alireza Fayyazpoor
2Student research committee, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afshin Borhani Haghighi
1Clinical neurology research center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniyal Salehi
2Student research committee, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hossein Molavi Vardanjan
3Department of MPH, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Poursadeghfard
1Clinical neurology research center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: poursadra@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Neurological disability associated with multiple sclerosis and immunosuppressive or immunomodulatory therapy which is administered for it may increases the risk of SARS-CoV-2 infection and its morbidity/mortality.

Objective In this study, we evaluated the infection rate and the severity of SARS-CoV-2 infection in patients with multiple sclerosis (MS)

Methods One thousand and three hundred and sixty one MS patients from Fars province, south of Iran, were interviewed by phone from April 3 to June 20, 2020. Basic demographic data, information about MS disease and any symptoms or laboratory results relevant to COVID-19 were gathered and reviewed by treating neurologist and MS nurses. SPSS version 22 was used for data analysis.

Results 68 (5%) of MS patients were suspected cases and 8 (0.58%) of all patients with positive real-time reverse transcription polymerase chain reaction (RT-PCR) or chest CT were in the confirmed group. 5 cases of the confirmed group needed hospitalization. Two patients died while both of them had PPMS and were taking rituximab. The frequency rate of suspected cases with RRMS was 57 (87.7%), followed by PPMS 5 (7.7%) and CIS 2(3.1%). In the confirmed group 37.5% had RRMS, 50% had PPMS, 25% use corticosteroid drug, and 50% were on rituximab. 62.5% of confirmed cases had high disability level and need assistance to walk. 36.8% of suspected and 25% of the confirmed cases were on IFN-β1; eventually all of them recovered well from COVID-19 infection.

Conclusion The present study showed that rate of developing COVID-19 in MS patients are similar to the general population and the frequency of PPMS phenotype, rituximab therapy and corticosteroid therapy were higher in the confirmed group.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

the financial resource of this project has been supported by Shiraz University of Medical Sciences.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This Cross-Sectional Study was approved by Iran National Committee for Ethics in Biomedical Research with the registration number IR.SUMS.REC.1399.26

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data related to this survey are available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional study
Mahnaz Bayat, Alireza Fayyazpoor, Afshin Borhani Haghighi, Daniyal Salehi, Hossein Molavi Vardanjan, Maryam Poursadeghfard
medRxiv 2020.10.17.20214429; doi: https://doi.org/10.1101/2020.10.17.20214429
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional study
Mahnaz Bayat, Alireza Fayyazpoor, Afshin Borhani Haghighi, Daniyal Salehi, Hossein Molavi Vardanjan, Maryam Poursadeghfard
medRxiv 2020.10.17.20214429; doi: https://doi.org/10.1101/2020.10.17.20214429

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4816)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (671)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (85)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5282)
  • Intensive Care and Critical Care Medicine (326)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (112)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (438)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (769)
  • Public and Global Health (1800)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)